RP

Renaud, Philip

OFFICER

CA·SEDI

Kane Biotech Inc.

0

Total declarations

0

Company

€621,900

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Renaud, Philip. Insider active across 1 company, notably Kane Biotech Inc.. In total, 4 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €622k. Activity tracked since 25 May 2026. The latest transaction was filed on 25 May 2026 (53 - Grant of warrants). Regulator: SEDI. All data is accessible without signup.

Declarations4 total

▲

Renaud, Philip

4 - Director of IssuerExecutives26 Jun 2025Kane Biotech Inc.

11SEDI ↗

@ €0.0627Convertible DebenturesTSXSEDI:4724819

Ideal exit: 23 Mar 2026 (T+270)

●

Renaud, Philip

4 - Director of IssuerExecutives15 Sept 2010Kane Biotech Inc.

11SEDI ↗

Convertible DebenturesTSXSEDI:4724814

●

Renaud, Philip

4 - Director of IssuerExecutives25 May 2026Kane Biotech Inc.

CA$1M16SEDI ↗

20,000,000 shares@ CA$0.0654.5% of flowWarrantsTSXSEDI:4724813

▲

Renaud, Philip

4 - Director of IssuerExecutives25 May 2026Kane Biotech Inc.

CA$1M16SEDI ↗

20,000,000 shares@ CA$0.0545.5% of flowCommon SharesTSXSEDI:4724810

Ideal exit: 19 Feb 2027 (T+270)

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

RP

Renaud, Philip

OFFICER

CA·SEDI

Kane Biotech Inc.

0

Total declarations

0

Company

€621,900

▲ Purchases (2 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Renaud, Philip. Insider active across 1 company, notably Kane Biotech Inc.. In total, 4 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €622k. Activity tracked since 25 May 2026. The latest transaction was filed on 25 May 2026 (53 - Grant of warrants). Regulator: SEDI. All data is accessible without signup.

Declarations4 total

▲

Renaud, Philip

4 - Director of IssuerExecutives26 Jun 2025Kane Biotech Inc.

11SEDI ↗

@ €0.0627Convertible DebenturesTSXSEDI:4724819